ROJKJAER LISA (EVP, Chief Medical Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 6/3/2026ACC: 0000905148-26-002809
Officer· EVP, Chief Medical Officer
Since Feb 2026
-850.00
Net shares
Net seller
$25.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
850.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−850.00
Price / share
$29.86
Trade value
$25.38K
% of position
2.4%
6/1/2026
34.85K→34K
Total
Net shares
−850.00
Net value
-$25.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | F · Tax Withholding | −850.00 | $29.86 | $25.38K | 2.4% | 34.85K | 34K |
| Total | −850.00 | -$25.38K | ||||||
Derivative Transactions0
No derivative transactions reported